article thumbnail

6 questions investors should ask when evaluating psychedelic biotech companies

TechCrunch

As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Contributor. Share on Twitter.

article thumbnail

Neko, Daniel Ek’s next play, is another spin on preventative healthcare

TechCrunch

Or so runs the pitch.) . “The Neko scan is a truly personalized experience centered around you, and it seamlessly tracks changes over time — so you do not have to,” Neko added. “Current healthcare systems and primary care processes were designed over half a century ago — and have barely changed since.